GW Pharmaceuticals Stock Flies After Cannabis Drug Sales Crush Estimates – Investor's Business Daily
GW Pharmaceuticals Stock Flies After Cannabis Drug Sales Crush Estimates Investor’s Business Daily
GW Pharmaceuticals stock rocketed late Tuesday after the biotech company said sales of cannabis medicine Epidiolex crushed estimates in the second quarter.
Source: Investment New Feed